Literature DB >> 21153530

Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes.

S Forbes1, S D Taylor-Robinson, N Patel, P Allan, B R Walker, D G Johnston.   

Abstract

AIMS/HYPOTHESIS: Non-alcoholic fatty liver disease (NAFLD) is common in type 2 diabetes but it is unknown whether NAFLD is prevalent in European women at risk of type 2 diabetes. We studied the prevalence of, and risk factors for, NAFLD in European women with previous gestational diabetes (GDM) at high risk of type 2 diabetes.
METHODS: A total of 110 women with previous GDM and 113 without previous GDM, with non-diabetic glucose tolerance were recruited retrospectively from antenatal databases. Participants underwent liver ultrasound scan examination, anthropometry and blood sampling for liver function tests and to determine levels of fasting lipids, NEFA and insulin and glucose concentrations in order to derive insulin sensitivity and insulin secretion indices (HOMA%S and HOMA%B, respectively).
RESULTS: There was no significant difference in BMI in women with previous GDM compared with those without previous GDM (28.9 ± 0.6 vs. 27.9 ± 0.6 kg/m(2), respectively; p = 0.12). Women with previous GDM had higher fasting and 2 h glucose concentrations following a 75 g OGTT ([mean ± SEM] fasting glucose 5.3 ± 0.1 vs. 5.1 ± 0.1 mmol/l, p = 0.02; 2 h glucose 6.8 ± 0.2 vs. 5.8 ± 0.3 mmol/l, p = 0.02), dyslipidaemia (LDL-cholesterol 3.3 ± 0.1 vs. 2.8 ± 0.1 mmol/l; HDL-cholesterol [median {interquartile range}] 1.3 [1.2-1.6] vs. 1.8 [1.5-1.9] mmol/l; triacylglycerol 1.3 [0.9-1.6] vs. 1.0 [0.7-1.7] mmol/l, all p ≤ 0.03), higher insulin secretion and lower insulin sensitivity. NAFLD prevalence was greater in women with previous GDM compared with those without previous GDM: 38% (95% CI 28-47%) vs. 17% (95% CI 10-24%), p = 0.001. In multiple logistic regression analysis, lower insulin sensitivity and raised serum alanine transaminase concentrations were associated with NAFLD. CONCLUSIONS/
INTERPRETATION: NAFLD is prevalent in European women with previous GDM. Impaired insulin sensitivity and increased liver transaminase activity are closely associated with NAFLD in these women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21153530     DOI: 10.1007/s00125-010-2009-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  23 in total

1.  Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.

Authors:  Gianfranco Pagano; Giovanni Pacini; Giovanni Musso; Roberto Gambino; Fabio Mecca; Nadia Depetris; Maurizio Cassader; Ezio David; Paolo Cavallo-Perin; Mario Rizzetto
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

2.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.

Authors:  Shivakumar Chitturi; Shehan Abeygunasekera; Geoffrey C Farrell; Jane Holmes-Walker; Jason M Hui; Caroline Fung; Rooshdiya Karim; Rita Lin; Dev Samarasinghe; Christopher Liddle; Martin Weltman; Jacob George
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

3.  Sustained endogenous glucose production, diminished lipolysis and non-esterified fatty acid appearance and oxidation in non-obese women at high risk of type 2 diabetes.

Authors:  Shareen Forbes; Stephen Robinson; Jason Dungu; Victor Anyaoku; Peter Bannister; David Forster; Sujata Dissanayake; Mark I McCarthy; Ian A MacDonald; Soundararajan Venkatesan; Desmond G Johnston
Journal:  Eur J Endocrinol       Date:  2006-09       Impact factor: 6.664

4.  Why does ethnicity affect prevalence of gestational diabetes? The underwater volcano theory.

Authors:  D K Yue; L M Molyneaux; G P Ross; M I Constantino; A G Child; J R Turtle
Journal:  Diabet Med       Date:  1996-08       Impact factor: 4.359

5.  Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome).

Authors:  P André; B Balkau; C Born; B Royer; E Wilpart; M A Charles; E Eschwège
Journal:  Diabetes Metab       Date:  2005-12       Impact factor: 6.041

6.  Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults.

Authors:  C-H Kim; J-Y Park; K-U Lee; J-H Kim; H-K Kim
Journal:  Diabet Med       Date:  2008-03-13       Impact factor: 4.359

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913.

Authors:  L O Ohlson; B Larsson; P Björntorp; H Eriksson; K Svärdsudd; L Welin; G Tibblin; L Wilhelmsen
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

9.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

10.  Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis.

Authors:  Abigail Fraser; Ross Harris; Naveed Sattar; Shah Ebrahim; George Davey Smith; Debbie A Lawlor
Journal:  Diabetes Care       Date:  2009-01-08       Impact factor: 17.152

View more
  24 in total

1.  Gestational diabetes in young women predicts future risk of serious liver disease.

Authors:  Ravi Retnakaran; Jin Luo; Baiju R Shah
Journal:  Diabetologia       Date:  2018-11-13       Impact factor: 10.122

2.  Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus.

Authors:  Seung Mi Lee; Soo Heon Kwak; Ja Nam Koo; Ig Hwan Oh; Jeong Eun Kwon; Byoung Jae Kim; Sun Min Kim; Sang Youn Kim; Gyoung Min Kim; Sae Kyung Joo; Bo Kyung Koo; Sue Shin; Chanthalakeo Vixay; Errol R Norwitz; Chan-Wook Park; Jong Kwan Jun; Won Kim; Joong Shin Park
Journal:  Diabetologia       Date:  2018-11-23       Impact factor: 10.122

3.  Implications of Nonalcoholic Fatty Liver Disease on Pregnancy and Maternal and Child Outcomes.

Authors:  Melissa Hershman; Rena Mei; Tatyana Kushner
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-04

4.  Prospective study of gestational diabetes and fatty liver scores 9 to 16 years after pregnancy.

Authors:  Sarah R Donnelly; Stefanie N Hinkle; Shristi Rawal; Louise G Grunnet; Jorge E Chavarro; Allan Vaag; Jing Wu; Peter Damm; James L Mills; Mengying Li; Anne A Bjerregaard; Anne Cathrine B Thuesen; Robert E Gore-Langton; Ellen C Francis; Sylvia H Ley; Frank B Hu; Michael Y Tsai; Sjurdur F Olsen; Cuilin Zhang
Journal:  J Diabetes       Date:  2019-06-12       Impact factor: 4.006

5.  Gestational Diabetes Mellitus Among Asians - A Systematic Review From a Population Health Perspective.

Authors:  Ling-Jun Li; Lihua Huang; Deirdre K Tobias; Cuilin Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

6.  Non-Alcoholic Fatty Liver Disease in Early Pregnancy Predicts Dysglycemia in Mid-Pregnancy: Prospective Study.

Authors:  Leanne R De Souza; Howard Berger; Ravi Retnakaran; Paraskevi A Vlachou; Jonathon L Maguire; Avery B Nathens; Philip W Connelly; Joel G Ray
Journal:  Am J Gastroenterol       Date:  2016-03-15       Impact factor: 10.864

7.  A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid.

Authors:  S Forbes; I F Godsland; S D Taylor-Robinson; J D Bell; E L Thomas; N Patel; G Hamilton; K H Parker; I Marshall; C D Gray; D Bedford; M Caslake; B R Walker; D G Johnston
Journal:  Diabetologia       Date:  2013-06-13       Impact factor: 10.122

8.  Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes.

Authors:  Latife Bozkurt; Christian S Göbl; Andrea Tura; Marek Chmelik; Thomas Prikoszovich; Lana Kosi; Oswald Wagner; Michael Roden; Giovanni Pacini; Amalia Gastaldelli; Alexandra Kautzky-Willer
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

9.  Maternal obesity is associated with the formation of small dense LDL and hypoadiponectinemia in the third trimester.

Authors:  Barbara J Meyer; Frances M Stewart; Elizabeth A Brown; Josephine Cooney; Solveig Nilsson; Gunilla Olivecrona; Jane E Ramsay; Bruce A Griffin; Muriel J Caslake; Dilys J Freeman
Journal:  J Clin Endocrinol Metab       Date:  2013-01-21       Impact factor: 5.958

10.  Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease.

Authors:  Veeral H Ajmera; Erica P Gunderson; Lisa B VanWagner; Cora E Lewis; John J Carr; Norah A Terrault
Journal:  Am J Gastroenterol       Date:  2016-03-22       Impact factor: 12.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.